Urol Oncol 41(252):e219–252.e227 Lowentritt B, Pilon D, Waters D et al (2023) Comparison of prostate-specific antigen response in patients with metastatic castration-sensitive prostate cancer initiated on apalutamide or abiraterone acetate: A retrospective cohort study. Here, KLK3 is linked to prostate cancer.